A prospective, single-center, phase II randomized controlled trial to evaluate the safety, feasibility, and preliminary efficacy of exercise during intravesical therapy for nonmuscle invasive bladder cancer.

被引：0
|
作者：
Arthuso, Fernanda Z. [1 ]
Fairey, Adrian S. [1 ]
Boule, Normand G. [1 ]
Courneya, Kerry S. [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.TPS600
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS600
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial
    Morielli, Andria R.
    Usmani, Nawaid
    Boule, Normand G.
    Severin, Diane
    Tankel, Keith
    Joseph, Kurian
    Nijjar, Tirath
    Fairchild, Alysa
    Courneya, Kerry S.
    CLINICAL COLORECTAL CANCER, 2021, 20 (03) : 216 - 226
  • [2] Bladder cancer and exeRcise trAining during intraVesical thErapy-the BRAVE trial: a study protocol for a prospective, single-centre, phase II randomised controlled trial
    Arthuso, Fernanda Z.
    Fairey, Adrian S.
    Boule, Normand G.
    Courneya, Kerry S.
    BMJ OPEN, 2021, 11 (09):
  • [3] Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study
    Ranjan, Ashish
    Misra, Ankit
    Sureka, Sanjoy Kumar
    Singh, Uday Pratap
    JOURNAL OF UROLOGY, 2023, 209 (04):
  • [4] Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study
    Lee, Hye Won
    Lee, Hyung Ho
    Park, Eun Young
    Park, Weon Seo
    Kim, Sung Han
    Joung, Jae Young
    Chung, Jinsoo
    Seo, Ho Kyung
    JOURNAL OF UROLOGY, 2023, 209 (01): : 131 - 139
  • [5] Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients with Nonmuscle- invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study
    Moschini, Marco
    Salonia, Andrea
    Briganti, Alberto
    Montorsi, Francesco
    EUROPEAN UROLOGY, 2023, 84 (04) : 439 - 440
  • [6] Feasibility and preliminary efficacy of an exercise telephone counseling intervention for hematologic cancer survivors: a phase II randomized controlled trial
    Vallerand, James R.
    Rhodes, Ryan E.
    Walker, Gordon J.
    Courneya, Kerry S.
    JOURNAL OF CANCER SURVIVORSHIP, 2018, 12 (03) : 357 - 370
  • [7] Feasibility and preliminary efficacy of an exercise telephone counseling intervention for hematologic cancer survivors: a phase II randomized controlled trial
    James R. Vallerand
    Ryan E. Rhodes
    Gordon J. Walker
    Kerry S. Courneya
    Journal of Cancer Survivorship, 2018, 12 : 357 - 370
  • [8] Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study. Letter.
    Peng, Chih-Kai
    Sung, Wen-Wei
    Chen, Sung-Lang
    JOURNAL OF UROLOGY, 2023, 209 (05): : 845 - 846
  • [9] Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: Single-center experience
    Zhu, Yaofeng
    Jiang, Xianzhou
    Zhang, Jianping
    Chen, Weili
    Shi, Benkang
    Xu, Zhishun
    UROLOGY, 2008, 72 (03) : 608 - 612
  • [10] Single course of intravesical Bacillus Calmette-Guerin versus single course with maintenance therapy in the management of nonmuscle invasive bladder cancer: A prospective randomized study
    Mohamed, Mohamed Bakr
    Ali, Mohamed Hassan
    Shamaa, Mostafa A.
    Shaaban, Sami M.
    UROLOGY ANNALS, 2020, 12 (04) : 360 - 365
12345